Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,063 | 55 | 33.4% |
| Consulting Fee | $2,820 | 2 | 30.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,679 | 4 | 18.3% |
| Travel and Lodging | $1,415 | 5 | 15.4% |
| Entertainment | $144.43 | 1 | 1.6% |
| Gift | $19.40 | 1 | 0.2% |
| Education | $17.84 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $3,393 | 16 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $1,679 | 4 | $0 (2023) |
| Alcon Laboratories Inc | $1,494 | 7 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $535.01 | 2 | $0 (2022) |
| Johnson & Johnson Surgical Vision, Inc. | $332.19 | 4 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $267.87 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $259.00 | 5 | $0 (2022) |
| Optos, Inc. | $243.10 | 2 | $0 (2023) |
| Allergan Inc. | $214.50 | 4 | $0 (2018) |
| Genentech, Inc. | $144.09 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,175 | 15 | Genentech USA, Inc. ($878.66) |
| 2023 | $4,528 | 17 | Genentech USA, Inc. ($2,263) |
| 2022 | $588.93 | 9 | Genentech USA, Inc. ($185.86) |
| 2021 | $494.53 | 11 | Johnson & Johnson Surgical Vision, Inc. ($121.95) |
| 2020 | $138.30 | 4 | Novartis Pharmaceuticals Corporation ($102.17) |
| 2019 | $125.00 | 1 | Novartis Pharmaceuticals Corporation ($125.00) |
| 2018 | $1,833 | 10 | Alcon Laboratories Inc ($1,219) |
| 2017 | $275.06 | 2 | Alcon Laboratories Inc ($275.06) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/09/2024 | Genentech USA, Inc. | Susvimo (Drug) | Consulting Fee | Cash or cash equivalent | $705.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/11/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 07/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 05/23/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $80.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/02/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $48.21 | General |
| Category: OPTOMETRY | ||||||
| 02/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/11/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $48.34 | General |
| Category: OPTOMETRY | ||||||
| 01/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $99.34 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/30/2023 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $577.60 | General |
| 12/30/2023 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $261.75 | General |
| 11/16/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $116.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/07/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/03/2023 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $577.60 | General |
| 09/14/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $23.15 | General |
| 09/07/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/17/2023 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $110.64 | General |
| Category: Optics | ||||||
| 08/07/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $123.64 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 999 | 10,761 | $1.1M | $465,576 |
| 2022 | 7 | 628 | 1,524 | $715,900 | $253,311 |
| 2021 | 8 | 451 | 941 | $392,928 | $138,706 |
| 2020 | 8 | 527 | 679 | $151,726 | $38,318 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 29 | 8,580 | $492,000 | $249,475 | 50.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 24 | 136 | $266,696 | $93,857 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 556 | $135,543 | $48,889 | 36.1% |
| 92134 | Imaging of retina | Office | 2023 | 289 | 763 | $80,374 | $21,520 | 26.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 57 | 226 | $52,360 | $19,821 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 153 | 153 | $55,674 | $16,120 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 90 | $24,237 | $6,041 | 24.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 122 | 133 | $7,319 | $2,490 | 34.0% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 11 | 13 | $15,886 | $2,442 | 15.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 14 | 39 | $5,042 | $2,155 | 42.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 42 | $2,847 | $1,888 | 66.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 14 | 30 | $6,401 | $877.15 | 13.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 29 | 234 | $456,952 | $168,035 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 415 | $100,728 | $38,231 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 144 | 144 | $52,399 | $16,197 | 30.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 47 | 168 | $39,191 | $14,814 | 37.8% |
| 92134 | Imaging of retina | Office | 2022 | 202 | 462 | $48,658 | $13,049 | 26.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 42 | 78 | $15,673 | $2,570 | 16.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 23 | 23 | $2,300 | $416.68 | 18.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 20 | 114 | $224,232 | $83,895 | 37.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 227 | $56,084 | $21,953 | 39.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 121 | 121 | $44,029 | $14,052 | 31.9% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 111 | 242 | $25,487 | $7,260 | 28.5% |
| 67028 | Injection of drug into eye | Office | 2021 | 21 | 71 | $16,449 | $6,325 | 38.5% |
| 76512 | Ultrasound of eye disease, growth, or structure | Office | 2021 | 55 | 118 | $20,308 | $4,208 | 20.7% |
About Dr. Fuad Makkouk, MD
Dr. Fuad Makkouk, MD is a Ophthalmology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1023454386.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fuad Makkouk, MD has received a total of $9,158 in payments from pharmaceutical and medical device companies, with $1,175 received in 2024. These payments were reported across 69 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,063).
As a Medicare-enrolled provider, Makkouk has provided services to 2,605 Medicare beneficiaries, totaling 13,905 services with total Medicare billing of $895,910. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Austin, TX
- Active Since 05/14/2013
- Last Updated 12/19/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1023454386
Products in Payments
- Susvimo (Drug) $2,820
- DAILIES (Device) $676.42
- Vabysmo (Drug) $321.68
- BEOVU (Drug) $259.00
- EYLEA HD (Biological) $237.72
- Tecnis Simplicity (Device) $232.59
- OZURDEX (Drug) $214.50
- EYLEA (Biological) $165.16
- PROKERA (Device) $147.46
- NFC-700 (Device) $144.43
- VABYSMO (Drug) $141.42
- TEPEZZA (Drug) $137.69
- AcrySof (Device) $117.95
- PANORAMIC OPHTHALMOSCOPE (Device) $98.67
- IHEEZO (Drug) $96.55
- Tecnis IOL (Device) $82.87
- RXSIGHT CONTACT LENS (Device) $80.74
- SUSVIMO (Drug) $73.95
- Lucentis (Biological) $64.97
- ILUVIEN (Drug) $42.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Austin
Vikram Durairaj, Md, MD
Ophthalmology — Payments: $516,103
Dr. Sheila Barbarino, M.d, M.D
Ophthalmology — Payments: $236,894
Dr. Thomas Walters, Md, MD
Ophthalmology — Payments: $217,539
Chirag Jhaveri, M.d, M.D
Ophthalmology — Payments: $211,408
Dr. Steven Dell, M.d, M.D
Ophthalmology — Payments: $177,840
Dr. Aaron Roller, M.d, M.D
Ophthalmology — Payments: $154,063